With landmark FDA approvals and IVDR compliance, breakthrough genomic, digital and blood-based biomarker discoveries, and rapid innovation in AI-driven diagnostics, precision medicine has never been more exciting.

Returning for its 15th anniversary this September, the World Clinical Biomarkers & Companion Diagnostics Summit will unite 600+ industry leaders across biopharma, CDx development, testing labs, regulators, and payers to advance clinical biomarker strategies and accelerate drug-diagnostics to market for improved patient diagnosis, stratification, and monitoring.

Join us in celebrating 15 years of progress, and be a part of the conversations and collaborations to define the next 15.